메뉴 건너뛰기




Volumn 64, Issue , 2002, Pages 181-200

Immunotherapy of colorectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD1 ANTIGEN; CD24 ANTIGEN; CEAVAC; EDRECOLOMAB; INTERLEUKIN 2 RECEPTOR; PEPTIDE; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; VACCINE; VIRUS VECTOR;

EID: 0036033539     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/64.1.181     Document Type: Review
Times cited : (10)

References (84)
  • 1
    • 0029925375 scopus 로고    scopus 로고
    • Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
    • Clemente CG, Mihm Jr MC, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303-10
    • (1996) Cancer , vol.77 , pp. 1303-1310
    • Clemente, C.G.1    Mihm M.C., Jr.2    Bufalino, R.3    Zurrida, S.4    Collini, P.5    Cascinelli, N.6
  • 2
    • 0034544532 scopus 로고    scopus 로고
    • A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response
    • Dunbar PR, Smith CL, Chao D et al. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol 2000; 165:6644-52
    • (2000) J Immunol , vol.165 , pp. 6644-6652
    • Dunbar, P.R.1    Smith, C.L.2    Chao, D.3
  • 3
    • 0032476616 scopus 로고    scopus 로고
    • Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T-lymphocytes
    • Romero P, Dunbar PR, Valmori D et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T-lymphocytes. J Exp Med 1998; 188: 1641-50
    • (1998) J Exp Med , vol.188 , pp. 1641-1650
    • Romero, P.1    Dunbar, P.R.2    Valmori, D.3
  • 4
    • 0030787373 scopus 로고    scopus 로고
    • Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
    • Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997; 182: 318-24
    • (1997) J Pathol , vol.182 , pp. 318-324
    • Ropponen, K.M.1    Eskelinen, M.J.2    Lipponen, P.K.3    Alhava, E.4    Kosma, V.M.5
  • 5
    • 0035060624 scopus 로고    scopus 로고
    • Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status
    • Michael-Robinson JM, Biemer-Huttmann A, Purdie DM et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 2001; 48: 360-6
    • (2001) Gut , vol.48 , pp. 360-366
    • Michael-Robinson, J.M.1    Biemer-Huttmann, A.2    Purdie, D.M.3
  • 6
    • 0034283019 scopus 로고    scopus 로고
    • Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer
    • Nagorsen D, Keilholz U, Rivoltini L et al. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res 2000; 60: 4850-4
    • (2000) Cancer Res , vol.60 , pp. 4850-4854
    • Nagorsen, D.1    Keilholz, U.2    Rivoltini, L.3
  • 8
    • 0028050181 scopus 로고
    • Structure, chromosomal localization, and expression of 12 genes of the MAGE family
    • De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360-9
    • (1994) Immunogenetics , vol.40 , pp. 360-369
    • De Plaen, E.1    Arden, K.2    Traversari, C.3
  • 9
    • 0028952240 scopus 로고
    • BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T-lymphocytes
    • Boel P, Wildmann C, Sensi ML et al. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T-lymphocytes. Immunity 1995; 2: 167-75
    • (1995) Immunity , vol.2 , pp. 167-175
    • Boel, P.1    Wildmann, C.2    Sensi, M.L.3
  • 10
    • 0033168930 scopus 로고    scopus 로고
    • Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
    • De Backer O, Arden KC, Boretti M et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999; 59: 3157-65
    • (1999) Cancer Res , vol.59 , pp. 3157-3165
    • De Backer, O.1    Arden, K.C.2    Boretti, M.3
  • 11
    • 1842398548 scopus 로고    scopus 로고
    • The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40
    • Tureci O, Sahin U, Schobert I et al. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996; 56: 4766-72
    • (1996) Cancer Res , vol.56 , pp. 4766-4772
    • Tureci, O.1    Sahin, U.2    Schobert, I.3
  • 12
    • 0030946527 scopus 로고    scopus 로고
    • Identification of potential HLA-A*0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA)
    • Ras E, van der Burg SH, Zegveld ST et al. Identification of potential HLA-A*0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA). Hum Immunol 1997; 53: 81-9
    • (1997) Hum Immunol , vol.53 , pp. 81-89
    • Ras, E.1    Van der Burg, S.H.2    Zegveld, S.T.3
  • 13
    • 0035874893 scopus 로고    scopus 로고
    • Generation of cytotoxic T-lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule
    • Trojan A, Witzens M, Schultze JL et al. Generation of cytotoxic T-lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule. Cancer Res 2001; 61: 4761-5
    • (2001) Cancer Res , vol.61 , pp. 4761-4765
    • Trojan, A.1    Witzens, M.2    Schultze, J.L.3
  • 14
    • 0033024724 scopus 로고    scopus 로고
    • Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma
    • Mosolits S, Harmenberg U, Ruden U et al. Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma. Cancer Immunol Immunother 1999; 47: 315-20
    • (1999) Cancer Immunol Immunother , vol.47 , pp. 315-320
    • Mosolits, S.1    Harmenberg, U.2    Ruden, U.3
  • 15
    • 0021345777 scopus 로고
    • Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues
    • Wagener C, Petzold P, Kohler W, Totovic V. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues. Int J Cancer 1984; 33: 469-75
    • (1984) Int J Cancer , vol.33 , pp. 469-475
    • Wagener, C.1    Petzold, P.2    Kohler, W.3    Totovic, V.4
  • 16
    • 0028022877 scopus 로고
    • Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients
    • Esteban JM, Felder B, Ahn C, Simpson JF, Battifora H, Shively JE. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients. Cancer 1994; 74: 1575-83
    • (1994) Cancer , vol.74 , pp. 1575-1583
    • Esteban, J.M.1    Felder, B.2    Ahn, C.3    Simpson, J.F.4    Battifora, H.5    Shively, J.E.6
  • 18
    • 0029042336 scopus 로고
    • Generation of human cytotoxic T-cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
    • Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Generation of human cytotoxic T-cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 1995; 87: 982-90
    • (1995) J Natl Cancer Inst , vol.87 , pp. 982-990
    • Tsang, K.Y.1    Zaremba, S.2    Nieroda, C.A.3    Zhu, M.Z.4    Hamilton, J.M.5    Schlom, J.6
  • 19
    • 0031937298 scopus 로고    scopus 로고
    • The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors
    • Kawashima I, Hudson SJ, Tsai V et al. The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum Immunol 1998; 59:1-14.
    • (1998) Hum Immunol , vol.59 , pp. 1-14
    • Kawashima, I.1    Hudson, S.J.2    Tsai, V.3
  • 20
    • 0033524378 scopus 로고    scopus 로고
    • Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T-lymphocyte
    • Nukaya I, Yasumoto M, Iwasaki T et al. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T-lymphocyte. Int J Cancer 1999; 80: 92-7
    • (1999) Int J Cancer , vol.80 , pp. 92-97
    • Nukaya, I.1    Yasumoto, M.2    Iwasaki, T.3
  • 21
    • 0026048664 scopus 로고
    • Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
    • Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344-66
    • (1991) J Clin Lab Anal , vol.5 , pp. 344-366
    • Thompson, J.A.1    Grunert, F.2    Zimmermann, W.3
  • 22
    • 0033616484 scopus 로고    scopus 로고
    • Colorectal cancer
    • Midgley R, Kerr D. Colorectal cancer. Lancet 1999; 353: 391-9
    • (1999) Lancet , vol.353 , pp. 391-399
    • Midgley, R.1    Kerr, D.2
  • 23
    • 0033025229 scopus 로고    scopus 로고
    • Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer
    • Ward RL, Hawkins NJ, Coomber D, Disis ML. Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer. Hum Immunol 1999; 60: 510-5
    • (1999) Hum Immunol , vol.60 , pp. 510-515
    • Ward, R.L.1    Hawkins, N.J.2    Coomber, D.3    Disis, M.L.4
  • 25
    • 0028989973 scopus 로고
    • MUC-1 epithelial tumor mucin-based immunity and cancer vaccines
    • Finn OJ, Jerome KR, Henderson RA et al. MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 1995; 145: 61-89
    • (1995) Immunol Rev , vol.145 , pp. 61-89
    • Finn, O.J.1    Jerome, K.R.2    Henderson, R.A.3
  • 26
    • 0028840265 scopus 로고
    • Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients
    • Gourevitch MM, von Mensdorff-Pouilly S, Litvinov SV et al. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer 1995; 72: 934-8
    • (1995) Br J Cancer , vol.72 , pp. 934-938
    • Gourevitch, M.M.1    Von Mensdorff-Pouilly, S.2    Litvinov, S.V.3
  • 27
    • 0025834851 scopus 로고
    • Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
    • Jerome KR, Barnd DL, Bendt KM et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 1991; 51: 2908-16
    • (1991) Cancer Res , vol.51 , pp. 2908-2916
    • Jerome, K.R.1    Barnd, D.L.2    Bendt, K.M.3
  • 28
    • 0028875822 scopus 로고
    • Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin
    • Domenech N, Henderson RA, Finn OJ. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J Immunol 1995; 155: 4766-74
    • (1995) J Immunol , vol.155 , pp. 4766-4774
    • Domenech, N.1    Henderson, R.A.2    Finn, O.J.3
  • 29
    • 0035254940 scopus 로고    scopus 로고
    • Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T- cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice
    • Heukamp LC, van der Burg SH, Drijfhout JW, Melief CJ, Taylor-Papadimitriou J, Offringa R. Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T- cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice. Int J Cancer 2001; 91: 385-92
    • (2001) Int J Cancer , vol.91 , pp. 385-392
    • Heukamp, L.C.1    Van der Burg, S.H.2    Drijfhout, J.W.3    Melief, C.J.4    Taylor-Papadimitriou, J.5    Offringa, R.6
  • 30
    • 0031905632 scopus 로고    scopus 로고
    • Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas
    • Gnjatic S, Cai Z, Viguier M, Chouaib S, Guillet JG, Choppin J. Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J Immunol 1998; 160: 328-33
    • (1998) J Immunol , vol.160 , pp. 328-333
    • Gnjatic, S.1    Cai, Z.2    Viguier, M.3    Chouaib, S.4    Guillet, J.G.5    Choppin, J.6
  • 31
    • 0035399602 scopus 로고    scopus 로고
    • Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens
    • Linnebacher M, Gebert J, Rudy W et al. Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens. Int J Cancer 2001; 93: 6-11
    • (2001) Int J Cancer , vol.93 , pp. 6-11
    • Linnebacher, M.1    Gebert, J.2    Rudy, W.3
  • 33
    • 0035818515 scopus 로고    scopus 로고
    • Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
    • Saeterdal I, Bjorheim J, Lislerud K et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 2001; 98: 13255-60
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 13255-13260
    • Saeterdal, I.1    Bjorheim, J.2    Lislerud, K.3
  • 36
    • 0029743737 scopus 로고    scopus 로고
    • Phenotypic analysis of antigen-specific T-lymphocytes
    • Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T-lymphocytes. Science 1996; 274: 94-6
    • (1996) Science , vol.274 , pp. 94-96
    • Altman, J.D.1    Moss, P.A.2    Goulder, P.J.3
  • 37
    • 0033564637 scopus 로고    scopus 로고
    • Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
    • Dunbar PR, Chen JL, Chao D et al. Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J Immunol 1999; 162: 6959-62
    • (1999) J Immunol , vol.162 , pp. 6959-6962
    • Dunbar, P.R.1    Chen, J.L.2    Chao, D.3
  • 38
    • 0034693390 scopus 로고    scopus 로고
    • Quantitation of antigen-reactive T-cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: A four-centre comparative trial
    • Scheibenbogen C, Romero P, Rivoltini L et al. Quantitation of antigen-reactive T-cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: A four-centre comparative trial. J Immunol Methods 2000; 244: 81-9
    • (2000) J Immunol Methods , vol.244 , pp. 81-89
    • Scheibenbogen, C.1    Romero, P.2    Rivoltini, L.3
  • 39
    • 0034600786 scopus 로고    scopus 로고
    • HIV-specific CD8(+) T-cells produce antiviral cytokines but are impaired in cytolytic function
    • Appay V, Nixon DF, Donahoe SM et al. HIV-specific CD8(+) T-cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192: 63-75
    • (2000) J Exp Med , vol.192 , pp. 63-75
    • Appay, V.1    Nixon, D.F.2    Donahoe, S.M.3
  • 40
    • 0031771557 scopus 로고    scopus 로고
    • Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen
    • Samanci A, Yi Q, Fagerberg J et al. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother 1998; 47: 131-42
    • (1998) Cancer Immunol Immunother , vol.47 , pp. 131-142
    • Samanci, A.1    Yi, Q.2    Fagerberg, J.3
  • 41
    • 0027512782 scopus 로고
    • Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-Year median follow-up of a phase III prospectively randomized trial
    • Hoover Jr HC, Brandhorst JS, Peters LC et al. Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-Year median follow-up of a phase III prospectively randomized trial. J Clin Oncol 1993; 11: 390-9
    • (1993) J Clin Oncol , vol.11 , pp. 390-399
    • Hoover H.C., Jr.1    Brandhorst, J.S.2    Peters, L.C.3
  • 42
    • 0033985949 scopus 로고    scopus 로고
    • Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283
    • Harris JE, Ryan L, Hoover Jr HC et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol 2000; 18: 148-57
    • (2000) J Clin Oncol , vol.18 , pp. 148-157
    • Harris, J.E.1    Ryan, L.2    Hoover H.C., Jr.3
  • 43
    • 0033616482 scopus 로고    scopus 로고
    • Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
    • Vermorken JB, Claessen AM, van Tinteren H et al. Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial. Lancet 1999; 353: 345-50
    • (1999) Lancet , vol.353 , pp. 345-350
    • Vermorken, J.B.1    Claessen, A.M.2    Van Tinteren, H.3
  • 44
    • 0029642252 scopus 로고
    • Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
    • Marchand M, Weynants P, Rankin E et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63: 883-5
    • (1995) Int J Cancer , vol.63 , pp. 883-885
    • Marchand, M.1    Weynants, P.2    Rankin, E.3
  • 46
    • 0031573840 scopus 로고    scopus 로고
    • + T-cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations
    • + T-cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations. Cell Immunol 1997; 182: 137-51
    • (1997) Cell Immunol , vol.182 , pp. 137-151
    • Abrams, S.I.1    Khleif, S.N.2    Bergmann-Leitner, E.S.3
  • 47
    • 0030749292 scopus 로고    scopus 로고
    • + T-lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
    • + T-lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int J Cancer 1997; 72: 784-90
    • (1997) Int J Cancer , vol.72 , pp. 784-790
    • Gjertsen, M.K.1    Bjorheim, J.2    Saeterdal, I.3    Myklebust, J.4    Gaudernack, G.5
  • 48
    • 0035866326 scopus 로고    scopus 로고
    • A striking property of recombinant poxviruses: Efficient inducers of in vivo expansion of primed CD8(+) T- cells
    • Zavala F, Rodrigues M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Esteban M. A striking property of recombinant poxviruses: Efficient inducers of in vivo expansion of primed CD8(+) T- cells. Virology 2001; 280: 155-9
    • (2001) Virology , vol.280 , pp. 155-159
    • Zavala, F.1    Rodrigues, M.2    Rodriguez, D.3    Rodriguez, J.R.4    Nussenzweig, R.S.5    Esteban, M.6
  • 49
    • 0031924077 scopus 로고    scopus 로고
    • + T-cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
    • + T-cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 1998; 4: 397-402
    • (1998) Nat Med , vol.4 , pp. 397-402
    • Schneider, J.1    Gilbert, S.C.2    Blanchard, T.J.3
  • 50
    • 0032033577 scopus 로고    scopus 로고
    • Enhancement of MHC class I-restricted peptide-specific T-cell induction by a DNA prime/MVA boost vaccination regime
    • Hanke T, Blanchard TJ, Schneider J et al. Enhancement of MHC class I-restricted peptide-specific T-cell induction by a DNA prime/MVA boost vaccination regime. Vaccine 1998; 16: 439-45
    • (1998) Vaccine , vol.16 , pp. 439-445
    • Hanke, T.1    Blanchard, T.J.2    Schneider, J.3
  • 51
    • 0000908124 scopus 로고
    • Phase I study of recombinant vaccinia virus (rV) that expresses human carcinoembryonic antigen (CEA) in adult patients with adenocarcinomas
    • Hamilton JM, Chen AP, Nguyen B et al. Phase I study of recombinant vaccinia virus (rV) that expresses human carcinoembryonic antigen (CEA) in adult patients with adenocarcinomas [abstract]. Proc ASCO 1994; 961
    • (1994) Proc ASCO , pp. 961
    • Hamilton, J.M.1    Chen, A.P.2    Nguyen, B.3
  • 52
    • 0033973608 scopus 로고    scopus 로고
    • Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine
    • Zhu MZ, Marshall J, Cole D, Schlom J, Tsang KY. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine. Clin Cancer Res 2000; 6: 24-33
    • (2000) Clin Cancer Res , vol.6 , pp. 24-33
    • Zhu, M.Z.1    Marshall, J.2    Cole, D.3    Schlom, J.4    Tsang, K.Y.5
  • 53
    • 0033766694 scopus 로고    scopus 로고
    • Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
    • Horig H, Lee DS, Conkright W et al. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol Immunother 2000; 49: 504-14
    • (2000) Cancer Immunol Immunother , vol.49 , pp. 504-514
    • Horig, H.1    Lee, D.S.2    Conkright, W.3
  • 54
    • 0034900416 scopus 로고    scopus 로고
    • The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma
    • von Mehren M, Arlen P, Gulley J et al. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res 2001; 7: 1181-91
    • (2001) Clin Cancer Res , vol.7 , pp. 1181-1191
    • Von Mehren, M.1    Arlen, P.2    Gulley, J.3
  • 55
    • 0034551730 scopus 로고    scopus 로고
    • Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
    • Marshall JL, Hoyer RJ, Toomey MA et al. Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J Clin Oncol 2000; 18: 3964-73
    • (2000) J Clin Oncol , vol.18 , pp. 3964-3973
    • Marshall, J.L.1    Hoyer, R.J.2    Toomey, M.A.3
  • 56
    • 0034880680 scopus 로고    scopus 로고
    • Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas
    • Sadanaga N, Nagashima H, Mashino K et al. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res 2001; 7: 2277-84
    • (2001) Clin Cancer Res , vol.7 , pp. 2277-2284
    • Sadanaga, N.1    Nagashima, H.2    Mashino, K.3
  • 57
    • 0033017065 scopus 로고    scopus 로고
    • A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
    • Morse MA, Deng Y, Coleman D et al. A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res 1999; 5:1331-8
    • (1999) Clin Cancer Res , vol.5 , pp. 1331-1338
    • Morse, M.A.1    Deng, Y.2    Coleman, D.3
  • 58
    • 0036124550 scopus 로고    scopus 로고
    • Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen
    • Itoh T, Ueda Y, Kawashima I et al. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Cancer Immunol Immunother 2002; 51:99-106
    • (2002) Cancer Immunol Immunother , vol.51 , pp. 99-106
    • Itoh, T.1    Ueda, Y.2    Kawashima, I.3
  • 59
    • 0035902607 scopus 로고    scopus 로고
    • Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
    • Fong L, Hou Y, Rivas A et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci USA 2001; 98: 8809-14
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 8809-8814
    • Fong, L.1    Hou, Y.2    Rivas, A.3
  • 60
    • 0030882684 scopus 로고    scopus 로고
    • Identification of an enhancer agonist cytotoxic T-lymphocyte peptide from human carcinoembryonic antigen
    • Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J. Identification of an enhancer agonist cytotoxic T-lymphocyte peptide from human carcinoembryonic antigen. Cancer Res 1997; 57: 4570-7
    • (1997) Cancer Res , vol.57 , pp. 4570-4577
    • Zaremba, S.1    Barzaga, E.2    Zhu, M.3    Soares, N.4    Tsang, K.Y.5    Schlom, J.6
  • 61
    • 0343965762 scopus 로고    scopus 로고
    • Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
    • Riethmuller G, Holz E, Schlimok G et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial. J Clin Oncol 1998; 16: 1788-94
    • (1998) J Clin Oncol , vol.16 , pp. 1788-1794
    • Riethmuller, G.1    Holz, E.2    Schlimok, G.3
  • 62
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-92
    • (2001) N Engl J Med , vol.344 , pp. 783-792
    • Slamon, D.J.1    Leyland-Jones, B.2    Shak, S.3
  • 63
    • 0027935133 scopus 로고
    • Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer
    • Welt S, Divgi CR, Kemeny N et al. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol 1994; 12: 1561-71
    • (1994) J Clin Oncol , vol.12 , pp. 1561-1571
    • Welt, S.1    Divgi, C.R.2    Kemeny, N.3
  • 64
    • 8944220716 scopus 로고    scopus 로고
    • Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer
    • Welt S, Scott AM, Divgi CR et al. Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol 1996; 14: 1787-97
    • (1996) J Clin Oncol , vol.14 , pp. 1787-1797
    • Welt, S.1    Scott, A.M.2    Divgi, C.R.3
  • 65
    • 0035884115 scopus 로고    scopus 로고
    • Serological analysis of human antihuman antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33
    • Ritter G, Cohen LS, Williams Jr C, Richards EC, Old LJ, Welt S. Serological analysis of human antihuman antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33. Cancer Res 2001; 61: 6851-9
    • (2001) Cancer Res , vol.61 , pp. 6851-6859
    • Ritter, G.1    Cohen, L.S.2    Williams C., Jr.3    Richards, E.C.4    Old, L.J.5    Welt, S.6
  • 66
    • 0015956495 scopus 로고
    • Towards a network theory of the immune system
    • Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974; 125C: 373-89
    • (1974) Ann Immunol (Paris) , vol.125 C , pp. 373-389
    • Jerne, N.K.1
  • 68
    • 0029992407 scopus 로고    scopus 로고
    • Mechanisms of loss of HLA class I expression on colorectal tumor cells
    • Browning M, Petronzelli F, Bicknell D et al. Mechanisms of loss of HLA class I expression on colorectal tumor cells. Tissue Antigens 1996; 47: 364-71
    • (1996) Tissue Antigens , vol.47 , pp. 364-371
    • Browning, M.1    Petronzelli, F.2    Bicknell, D.3
  • 69
    • 0035796591 scopus 로고    scopus 로고
    • The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR)
    • Meyaard L, van der Vuurst de Vries AR, de Ruiter T, Lanier LL, Phillips JH, Clevers H. The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR). J Exp Med 2001; 194: 107-12
    • (2001) J Exp Med , vol.194 , pp. 107-112
    • Meyaard, L.1    Van der Vuurst de Vries, A.R.2    De Ruiter, T.3    Lanier, L.L.4    Phillips, J.H.5    Clevers, H.6
  • 70
    • 0035180067 scopus 로고    scopus 로고
    • Control of intestinal inflammation by regulatory T-cells
    • Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T-cells. Immunol Rev 2001; 182: 190-200
    • (2001) Immunol Rev , vol.182 , pp. 190-200
    • Singh, B.1    Read, S.2    Asseman, C.3
  • 71
    • 0030902366 scopus 로고    scopus 로고
    • The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma
    • Coca S, Perez-Piqueras J, Martinez D et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997; 79: 2320-8
    • (1997) Cancer , vol.79 , pp. 2320-2328
    • Coca, S.1    Perez-Piqueras, J.2    Martinez, D.3
  • 72
    • 0037017387 scopus 로고    scopus 로고
    • Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK-cells
    • Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK-cells. J Exp Med 2002; 195: 343-51
    • (2002) J Exp Med , vol.195 , pp. 343-351
    • Ferlazzo, G.1    Tsang, M.L.2    Moretta, L.3    Melioli, G.4    Steinman, R.M.5    Munz, C.6
  • 73
    • 0037017379 scopus 로고    scopus 로고
    • Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells
    • Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002; 195: 335-41
    • (2002) J Exp Med , vol.195 , pp. 335-341
    • Piccioli, D.1    Sbrana, S.2    Melandri, E.3    Valiante, N.M.4
  • 74
    • 0033618504 scopus 로고    scopus 로고
    • Activation of NK-cells and T-cells by NKG2D, a receptor for stress-inducible MICA
    • Bauer S, Groh V, Wu J et al. Activation of NK-cells and T-cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-9
    • (1999) Science , vol.285 , pp. 727-729
    • Bauer, S.1    Groh, V.2    Wu, J.3
  • 75
    • 0029861713 scopus 로고    scopus 로고
    • Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
    • Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996; 93: 12445-50
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 12445-12450
    • Groh, V.1    Bahram, S.2    Bauer, S.3    Herman, A.4    Beauchamp, M.5    Spies, T.6
  • 76
    • 0035054469 scopus 로고    scopus 로고
    • Role of NKG2D in tumor cell lysis mediated by human NK-cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
    • Pende D, Cantoni C, Rivera P et al. Role of NKG2D in tumor cell lysis mediated by human NK-cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 2001; 31: 1076-86
    • (2001) Eur J Immunol , vol.31 , pp. 1076-1086
    • Pende, D.1    Cantoni, C.2    Rivera, P.3
  • 77
    • 0035286345 scopus 로고    scopus 로고
    • Co-stimulation of CD8alphabeta T-cells by NKG2D via engagement by MIC induced on virus-infected cells
    • Groh V, Rhinehart R, Randolph-Habecker J, Topp M, Riddell S, Spies T. Co-stimulation of CD8alphabeta T-cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255-60
    • (2001) Nat Immunol , vol.2 , pp. 255-260
    • Groh, V.1    Rhinehart, R.2    Randolph-Habecker, J.3    Topp, M.4    Riddell, S.5    Spies, T.6
  • 78
    • 0035949563 scopus 로고    scopus 로고
    • Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
    • Cerwenka A, Baron J, Lanier L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 2001; 98: 11521-6
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 11521-11526
    • Cerwenka, A.1    Baron, J.2    Lanier, L.3
  • 79
    • 0035855872 scopus 로고    scopus 로고
    • Rael and H60 ligands of the NKG2D receptor stimulate turnout immunity
    • Diefenbach A, Jensen E, Jamieson A, Raulet D. Rael and H60 ligands of the NKG2D receptor stimulate turnout immunity. Nature 2001; 413: 165-71
    • (2001) Nature , vol.413 , pp. 165-171
    • Diefenbach, A.1    Jensen, E.2    Jamieson, A.3    Raulet, D.4
  • 80
    • 0035914134 scopus 로고    scopus 로고
    • Regulation of cutaneous malignancy by gamma delta T cells
    • Girardi M, Oppenheim D, Steele C et al. Regulation of cutaneous malignancy by gamma delta T cells. Science 2001; 294: 605-9
    • (2001) Science , vol.294 , pp. 605-609
    • Girardi, M.1    Oppenheim, D.2    Steele, C.3
  • 83
    • 0036591697 scopus 로고    scopus 로고
    • Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha- galactosylceramide by human CD4(+) and CD8alphabeta(+) T-lymphocytes
    • Gadola SD, Dulphy N, Salio M, Cerundolo V. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha- galactosylceramide by human CD4(+) and CD8alphabeta(+) T-lymphocytes. J Immunol 2002; 168: 5514-20
    • (2002) J Immunol , vol.168 , pp. 5514-5520
    • Gadola, S.D.1    Dulphy, N.2    Salio, M.3    Cerundolo, V.4
  • 84
    • 0033405176 scopus 로고    scopus 로고
    • The intestinal epithelial cell: Processing and presentation of antigen to the mucosal immune system
    • Campbell N, Yio XY, So LP, Li Y, Mayer L. The intestinal epithelial cell: Processing and presentation of antigen to the mucosal immune system. Immunol Rev 1999; 172: 315-24
    • (1999) Immunol Rev , vol.172 , pp. 315-324
    • Campbell, N.1    Yio, X.Y.2    So, L.P.3    Li, Y.4    Mayer, L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.